The Valley Desk

ArticleRheumatology and therapyPublished

Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post hoc Analyses of Two Phase 3 Trials

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Rheumatology and therapy
Published
Subject terms
Pain; Fatigue; Psoriatic Arthritis; Joint Disease; Physical Function; Disease Activity; Patient-reported Outcome; Guselkumab; Skin Psoriasis; Minimal Clinically Meaningful Improvement
PubMed ID
39261446
PubMed Central ID
PMC11557817
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal